With its antioxidant properties, hydrogen gas (H2) has been evaluated in vitro, in animal
studies and in human studies for a broad range of therapeutic indications. A simple search …

Ischemia/reperfusion injury (IRI) represents a significant contributor to morbidity and
mortality associated with various clinical conditions, including acute coronary syndrome …

Purpose Metabolic syndrome is associated with several medical risk factors including
dyslipidemia, hyperglycemia, and obesity, which has become a worldwide pandemic. The …

Hydrogen therapy is an emerging and promising therapy strategy of using molecular
hydrogen as a new type of safe and effective therapeutic agent, exhibiting remarkable …

Dynamic variations in the concentration and abnormal distribution of endogenous
biomarkers are strongly associated with multiple physiological and pathological states …

Hydrogen therapy, leveraging its selective attenuation of hydroxyl radicals (˙ OH) and
ONOO−, has emerged as a pivotal pathophysiological modulator with antioxidant, anti …

Over the last two decades, a plethora of disease models and human studies have confirmed
the beneficial effects of molecular hydrogen (H2), a simple biotherapeutic gas. Recent small …

Oxidative stress and chronic inflammation have been implicated in the pathophysiology of
metabolic diseases, including diabetes mellitus (DM), metabolic syndrome (MS), fatty liver …

Ever since molecular hydrogen was first reported as a hydroxyl radical scavenger in 2007,
the beneficial effect of hydrogen was documented in more than 170 disease models and …

The gas molecules O2, NO, H2S, CO, and CH4, have been increasingly used for medical
purposes. Other than these gas molecules, H2 is the smallest diatomic molecule in nature …